Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Cerebral Therapeutics announces enrolment of first patient in phase 2b trial in epilepsy

pharmaceutical-business-reviewNovember 20, 2020

Tag: Cerebral Therapeutics , Epilepsy , CT-010

PharmaSources Customer Service